- Home
- PMT vs COGT Comparison
PMT vs COGT Comparison
Compare PMT & COGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMT
- COGT
- Stock Information
- Founded
- PMT 2009
- COGT 2014
- Country
- PMT United States
- COGT United States
- Employees
- PMT N/A
- COGT N/A
- Industry
- PMT Real Estate Investment Trusts
- COGT Biotechnology: Pharmaceutical Preparations
- Sector
- PMT Real Estate
- COGT Health Care
- Exchange
- PMT Nasdaq
- COGT Nasdaq
- Market Cap
- PMT 1.2B
- COGT 1.0B
- IPO Year
- PMT 2009
- COGT 2018
- Fundamental
- Price
- PMT $14.50
- COGT $7.30
- Analyst Decision
- PMT Buy
- COGT Buy
- Analyst Count
- PMT 6
- COGT 7
- Target Price
- PMT $15.25
- COGT $14.17
- AVG Volume (30 Days)
- PMT 689.6K
- COGT 1.2M
- Earning Date
- PMT 04-23-2025
- COGT 05-06-2025
- Dividend Yield
- PMT 11.22%
- COGT N/A
- EPS Growth
- PMT N/A
- COGT N/A
- EPS
- PMT 1.37
- COGT N/A
- Revenue
- PMT $504,603,000.00
- COGT N/A
- Revenue This Year
- PMT N/A
- COGT N/A
- Revenue Next Year
- PMT $1.57
- COGT N/A
- P/E Ratio
- PMT $10.43
- COGT N/A
- Revenue Growth
- PMT N/A
- COGT N/A
- 52 Week Low
- PMT $11.77
- COGT $5.73
- 52 Week High
- PMT $15.22
- COGT $12.61
- Technical
- Relative Strength Index (RSI)
- PMT 54.80
- COGT 45.26
- Support Level
- PMT $14.14
- COGT $6.60
- Resistance Level
- PMT $14.93
- COGT $7.76
- Average True Range (ATR)
- PMT 0.29
- COGT 0.58
- MACD
- PMT -0.06
- COGT 0.03
- Stochastic Oscillator
- PMT 23.86
- COGT 50.69
About PMT PennyMac Mortgage Investment Trust of Beneficial Interest
PennyMac Mortgage Investment Trust is a specialty finance company that invests primarily in residential mortgage loans and mortgage-related assets. The company's operations include activities such as the production and servicing of financial securities based on residential loans and the pooling and reselling of high-credit-quality mortgages. The company operates through three segments: correspondent production, credit-sensitive strategies, interest-rate-sensitive strategies. The Credit sensitive strategies segment generates income via investments in CRT arrangements, subordinate MBS, distressed loans, and real estate.
About COGT Cogent Biosciences Inc.
Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with strong dependence on oncogenic KIT signaling.